• Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Provider Compendium
    June 26, 2026

    Healthcare payers are operating in an increasingly complex environment shaped by volatile medical costs, constrained premium growth, evolving regulatory requirements, fragmented legacy systems, and continued workforce constraints. These pressures are pushing health plans to move beyond…
  • Viewpoint
    June 16, 2026

    Healthcare payer operations are reaching a key inflection point as demographic shifts, chronic disease growth, regulatory requirements, margin pressures, workforce shortages, and rising member expectations expose the limitations of fragmented operating models. Simultaneously, internal constraints such…
  • Tech Provider Spotlight
    June 12, 2026

    Healthcare payer risk and quality management is shifting from fragmented, retrospective, and manual workflows to integrated, evidence-led operating models. Payers are under pressure to improve risk capture, strengthen Healthcare Effectiveness Data and Information Set (HEDIS) and…
  • Viewpoint
    June 02, 2026

    Healthcare payers are under pressure to modernize operations as margin compression, high medical loss ratios, regulatory mandates, cybersecurity exposure, and rising member expectations expose the limits of legacy operating models. Traditional Business-Process-as-a-Service (BPaaS) models have helped…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Blog
    April 28, 2026

    The marketplace is changing. Two marquee moves in July reset expectations for how large service providers will deliver operations at scale: Capgemini agreed to acquire WNS to build an agentic‑Artificial Intelligence (AI) powered intelligent operations leader,…
  • Roundtable
    April 16, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Thursday, May 07, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • Roundtable
    March 31, 2026

    Following our GBS Operating Model FutureCast workshop, Everest Group is convening a select group of GBS leaders for an interactive working session on Tuesday, April 14, to pressure test emerging perspectives on reimagining the operating model in the age of agentic AI.  …
  • LinkedIn Live
    Feb. 24, 2026

    Payer operations were reaching a structural inflection point. As cost pressure, regulatory scrutiny, and AI-enabled operating models reshaped the landscape, payer leaders had to rethink how sourcing and operating design delivered measurable business outcomes. In this…
  • PEAK Matrix®
    Feb. 19, 2026

    Healthcare payers are navigating volatile medical costs, limited premium growth, and fragmented legacy systems. At the same time, regulatory and quality requirements are intensifying, with the Centers for Medicare and Medicaid Services (CMS) advancing interoperability and…
  • Blog
    Nov. 18, 2025

    The next chapter of payer operations   The US healthcare landscape is grappling with rising costs, regulatory pressure, and eroding trust. Major payers such as UnitedHealth Group, Elevance, Humana, and CVS Health are reporting medical loss ratios (MLRs) near 88-90%, squeezing margins…
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • In 2006, I visited my first captive center in Bengaluru. At the time, the model was still in its formative years – many multinational organizations were only beginning to explore the potential of setting up their own in-house centers…
  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • State of the Market
    Oct. 31, 2025

    Clinical and Care Management (CCM) is becoming a strategic priority for healthcare enterprises, driven by the need to improve outcomes, contain costs, and comply with intensifying regulatory demands. Once seen primarily as a cost-control function, CCM…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • LinkedIn Live
    July 24, 2025

    Watch on LinkedIn Global Capability Centers (GCCs) in India rapidly evolved from cost-efficient service hubs to strategic centers of innovation, product development, and digital transformation for global enterprises. As this evolution accelerated, talent development became a…
  • July 23, 2025

    What happened: The big picture behind the One Big Beautiful Bill Act The One Big Beautiful Bill Act (OBBBA) delivers sweeping fiscal reforms aimed at reducing federal healthcare spending, most notably through a US $1 trillion…

Items per page